The latest press, media features, and thought leadership highlighting RILA's role in shaping global insights and narratives.
RILA played a critical role in supporting the recent FDA approval of a breakthrough oncology therapy designed for patients with limited treatment options after first-line chemotherapy. Acting as a strategic insights partner, RILA provided end-to-end intelligence—from identifying and engaging key opinion leaders to conducting patient unmet-needs analysis, complaint listening, and investor relations research. Our integrated approach combined social listening, pharmacovigilance, and competitive intelligence to guide scientific communication, regulatory readiness, and launch strategy. This approval not only represents an important advancement for patients and the oncology community but also highlights how RILA’s data-driven, patient-informed methodologies empower biopharma companies to bring meaningful, evidence-based innovations to market.
October 14, 2025
READ MORE
RILA’s newly earned WBE and WOSB certifications mark more than a milestone—they signal a shift in how organizations can approach supplier diversity, innovation, and data-driven decision-making. By combining elite certifications in governance, compliance, and pharmacovigilance with a proven track record of helping Fortune 500 companies navigate change, RILA positions itself as a catalyst for smarter, more inclusive business strategies. This is not just recognition of a women-owned firm’s excellence—it’s an invitation for brands to reimagine what “best-in-class” looks like in a world where diversity, trust, and insight fuel competitive advantage.
September 26, 2025
RILA Global Consulting’s flawless completion of a rigorous pharmacovigilance audit isn’t just a regulatory win — it’s a statement about the future of life sciences. In an era where pharmaceutical companies are under relentless scrutiny, RILA’s zero-finding result underscores the power of combining strict compliance with data-driven insights.
September 17, 2025
July CPI report shows inflation at 2.7% as Trump’s tariffs add moderate pressure on prices. Experts note stable trends but rising core inflation.
August 12, 2025
Core Power shakes are a hit with Ozempic users — but experts warn the protein-packed drink may be the most unhealthy bottled beverage in America.
June 4, 2025
For Tsvetta Kaleynska, entrepreneurship is about vision, resilience, and impact. As the Founder and CEO of RILA GLOBAL CONSULTING, she leads a premier agency specializing in advanced consumer intelligence, helping Fortune 500 companies navigate the digital landscape. An immigrant entrepreneur, author, and TV commentator, Tsvetta has been featured in Forbes, Fortune, NY Post, and more, and is a passionate advocate for women in business and technology.
January 31, 2025
Sources who spoke to HR Dive stressed the need for business continuity planning and collaboration with payroll vendors where applicable.
July 26, 2024
Businesses from airlines to hospitals have been grappling with a faulty software update that caused technological havoc worldwide on Friday, and its repercussions continued through the weekend.
July 21, 2024
Major customers of Microsoft and CrowdStrike are getting IT support to resolve the issues stemming from a faulty software update that caused technological havoc worldwide on Friday, but smaller businesses whose computers may have received the problematic update are struggling.
New York District Attorney Alvin Bragg scored a 56% in negative sentiment — representing 483,000 posts — in discussions, articles and mentions across various platforms in the US.
June 29, 2024
Ozempic and Mounjaro users are increasingly turning to protein drinks as a convenient way to supplement protein consumption and combat excess muscle loss.
June 22, 2024
Consumer-facing companies are tapping into buyers’ emotions as they redesign logos and packaging.
February 27, 2024
Some are continuing social impact initiatives but have chosen not to share what they are doing.
June 16, 2023
Insights That Matter. Straight to You.
Sign up to receive RILA's latest press coverage, thought leadership, and industry news.
